SPOTLIGHT -
Final Thoughts on Case Study and Treating Multiple Myeloma
Dr Joseph Mikhael and expert panel re-visit the patient case and offer their final thoughts on the impact of clinical trial updates in the treatment landscape of multiple myeloma.
Read More
Clinical Trials in R/R Multiple Myeloma
Dr Joseph Mikhael and expert panel discuss key efficacy and safety outcomes of pivotal clinical trials evaluating treatment regimens in patients with R/R multiple myeloma.
Treatment Options in Early Relapse Multiple Myeloma
Dr Joseph Mikhael and expert panel review current treatment options for patients with early relapse multiple myeloma, in accordance with current NCCN guidelines.
Case Study: Myeloma at Early Relapse
Dr Joseph Mikhael and expert panel review a case study in early relapse multiple myeloma and the impact of cytogenetics in risk assessment for patients with early relapse multiple myeloma.
Frontline Therapy in Multiple Myeloma
Joseph Mikhael, MD, discusses diagnosis criteria and treatment considerations for patients with multiple myeloma in the frontline setting.
Putting Culturally Competent Care into Practice
Joseph Mikhael, MD, and Craig Cole, MD, close the program by sharing examples of times culturally competent care was paramount to the treatment of their patients.
Disparities in Multiple Myeloma Care: The Path Toward Health Equity
Expert panelists share their closing thoughts on the path to improve health equity in multiple myeloma management for racial and ethnic minority groups.
Advice on Delivering Culturally Competent Care for Community Physicians
Craig Cole, MD, shares advice for community physicians on providing culturally competent care to patients with multiple myeloma that embraces their beliefs, spiritualities, and ethnicities.
The Barriers to Quality Care for Black American Patients with Multiple Myeloma
A key opinion leader lists the factors that affect access to quality care for Black Americans with multiple myeloma.
Addressing Healthcare Provider Bias in Multiple Myeloma Management
Joint consideration for physician bias in the management of multiple myeloma and how it can be addressed while treating patients belonging to racial and ethnic minority groups.
Improving Access to Clinical Trials in Multiple Myeloma
Centering discussion clinical trials in multiple myeloma, panelists review how to improve access to these studies for racial and ethnic minority groups.
Multiple Myeloma Clinical Trial Enrollment in the Black American Population
An expert discusses the stigmas behind clinical trials and the shockingly low rate of enrollment by Black Americans with multiple myeloma.
Spreading Multiple Myeloma Awareness in the Local Community
Dr Craig Cole explains why awareness about multiple myeloma needs to be raised in Black American communities by healthcare workers.
Improving Access to Specialty Care in Multiple Myeloma
Experts on multiple myeloma share comprehensive insight on how to build better access to specialty care for patients of racial and ethnic minority groups.
Overcoming Barriers to Early Diagnosis in Multiple Myeloma
Expert perspectives on how to improve the early detection of multiple myeloma within patients belonging to racial and ethnic minority groups.
Barriers in the Diagnosis of Multiple Myeloma for Patients
Craig Cole, MD, describes the barriers that can affect the diagnosis of multiple myeloma.
Examining the Roots of Health Disparities in Multiple Myeloma
Joseph Mikhael, MD, introduces the topic of disparities in multiple myeloma and the concept of multicultural health care.
Multiple Myeloma: Disparities in Access to Transplantation and Novel Therapy
Closing out their review of the barriers racial and ethnic minority groups encounter in receiving care, expert panelists address access to transplantation or novel therapy.
Multiple Myeloma: Disparities in Access to Specialized Care
Comprehensive discussion on access to specialized care and how racial and ethnic minority groups encounter barriers in this setting.
Multiple Myeloma: Disparities in Time to Diagnosis
Panelists address how racial and ethnic minority groups experience disparity in time to diagnosis within the multiple myeloma treatment pathway.
Societal Determinants of Health in Multiple Myeloma
Expert panelists shift their attention to how social determinants of multiple myeloma impact the treatment received by racial and ethnic minority groups.
Biological Determinants of Health in Multiple Myeloma
Focused discussion on the biological determinants of multiple myeloma and how its prevalence is reflected in racial and ethnic minority groups.
Overview of Multiple Myeloma and Health Equity
Joseph Mikhael, MD, spearheads an overview on the prevalence of multiple myeloma in racial and ethnic minority groups in the context of health equity.
Addition of Isatuximab to RVd as Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma (GMMG-HD7)
Expert hematologist/oncologist Joseph Mikhael, MD, shares insight on the phase III GMMG-HD7 trial, which added isatuximab to RVd in the setting of newly diagnosed, transplant-eligible multiple myeloma.
Dr. Mikhael on the Promise of Bispecific Antibodies in Multiple Myeloma
Joseph Mikhael, MD, discusses the promise of bispecific antibodies in multiple myeloma.
Dr. Mikhael on Treatment Selection for Early Relapse in Multiple Myeloma
Joseph Mikhael, MD, discusses treatment selection for early relapse in multiple myeloma.
Dr. Mikhael on the Advances Made in Multiple Myeloma Treatment
Joseph Mikhael, MD, discusses novel agents used to treat patients with multiple myeloma.
Dr. Mikhael on Remaining Challenges in High-Risk Multiple Myeloma
Joseph Mikhael, MD, discusses remaining challenges in high-risk multiple myeloma.
Dr. Mikhael on Unmet Needs in Triple-Class Refractory Multiple Myeloma
Joseph Mikhael, MD, discusses unmet needs in triple-class refractory multiple myeloma.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making